Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research - Alzheimer Disorders

Volume 5

eBook: US $39 Special Offer (PDF + Printed Copy): US $174
Printed Copy: US $155
Library License: US $156
ISSN: 2451-8743 (Print)
ISSN: 2214-5168 (Online)
ISBN: 978-1-68108-232-5 (Print)
ISBN: 978-1-68108-231-8 (Online)
Year of Publication: 2016
DOI: 10.2174/97816810823181160501

Introduction

Frontiers in Clinical Drug Research - Alzheimer Disorders is an e-Book series which covers recent topics related to understanding Alzheimer's disease (AD) that causes dementia and has a neurodegenerative effect on the brain. The disease affects memory, thought process, and language of affected individuals. Chapters in each volume focus on (Alzheimer Disorders) drug research with special emphasis on clinical trials, research on drugs in advanced stages of development and cure for Alzheimer’s disease and related disorders.

Frontiers in Clinical Drug Research - Alzheimer Disorders will be of particular interest to readers interested in drug therapy of this specific neurodegenerative condition and related brain disorders as the series provides relevant reviews written by experts in field of Alzheimer’s Disease research.

The fifth volume of this series features chapters covering critical discussions on AD management and new therapies. The topics reviewed in this volume include:

- Current concepts in management of AD

- The amyloid cascade hypothesis and stem cell-based AD therapy

- Phytochemicals targeting AD

- Dementia screening in primary clinical care settings

- Updates in dementia / AD clinical research and drug development

ADD A COMMENT

Your Rating *

RELATED BOOKS

.Frontiers in Clinical Drug Research - CNS and Neurological Disorders.
.Frontiers in Clinical Drug Research - CNS and Neurological Disorders.
.Neurodegenerative Diseases: Multifactorial Degenerative Processes, Biomarkers and Therapeutic Approaches.
.Frontiers in Clinical Drug Research - CNS and Neurological Disorders.
.Traditional Medicine for Neuronal Health.
.Recent Advances in the Treatment of Neurodegenerative Disorders.
.Alzheimer
.Advances in Alzheimer Research.